• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成和动脉生成因子的组合蛋白疗法显著改善了猪的侧支循环形成和心脏功能。

Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs.

作者信息

Lu Huixia, Xu Xinsheng, Zhang Mei, Cao Renhai, Bråkenhielm Ebba, Li Changjiang, Lin Huili, Yao Guihua, Sun Huiwen, Qi Lihang, Tang Mengxiong, Dai Hongyan, Zhang Yanen, Su Runyi, Bi Yanwen, Zhang Yun, Cao Yihai

机构信息

Key Laboratory of Cardiovascular Remodelling and Function Research, Chinese Ministry of Education and Public Health, Qi Lu Hospital, Shandong University, Jinan 250012, Shandong Province, People's Republic of China.

出版信息

Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12140-5. doi: 10.1073/pnas.0704966104. Epub 2007 Jul 16.

DOI:10.1073/pnas.0704966104
PMID:17636133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1920536/
Abstract

Establishment of functional and stable collaterals in the ischemic myocardium is crucial to restoring cardiac function after myocardial infarction. Here, we show that only dual delivery of a combination of angiogenic and arteriogenic factors to the ischemic myocardium could significantly reestablish stable collateral networks and improve myocardial perfusion and function. A combination of FGF-2 with PDGF-BB, two factors primarily targeting endothelial cells and vascular smooth muscle cells, remarkably promotes myocardial collateral growth and stabilizes the newly formed collateral networks, which significantly restore myocardial perfusion and function. Using various members of the PDGF family together with FGF-2 in an angiogenesis assay, we demonstrate that PDGFR-alpha is mainly involved in angiogenic synergism, whereas PDGFR-beta mediates vessel stability signals. Our findings provide conceptual guidelines for the clinical development of proangiogenic/arteriogenic factors for the treatment of ischemic heart disease.

摘要

在缺血心肌中建立功能性和稳定的侧支循环对于心肌梗死后恢复心脏功能至关重要。在此,我们表明,仅向缺血心肌双重递送血管生成因子和动脉生成因子的组合,可显著重建稳定的侧支循环网络,并改善心肌灌注和功能。FGF-2与PDGF-BB(两种主要靶向内皮细胞和血管平滑肌细胞的因子)的组合,可显著促进心肌侧支生长并稳定新形成的侧支循环网络,从而显著恢复心肌灌注和功能。在血管生成试验中,将PDGF家族的各种成员与FGF-2一起使用,我们证明PDGFR-α主要参与血管生成协同作用,而PDGFR-β介导血管稳定性信号。我们的研究结果为用于治疗缺血性心脏病的促血管生成/动脉生成因子的临床开发提供了概念性指导方针。

相似文献

1
Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs.血管生成和动脉生成因子的组合蛋白疗法显著改善了猪的侧支循环形成和心脏功能。
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12140-5. doi: 10.1073/pnas.0704966104. Epub 2007 Jul 16.
2
Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability.血小板衍生生长因子受体α(PDGFR-α)和血小板衍生生长因子受体β(PDGFR-β)在血管生成和血管稳定性中的不同作用。
FASEB J. 2009 Jan;23(1):153-63. doi: 10.1096/fj.08-113860. Epub 2008 Sep 30.
3
Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2.血小板衍生生长因子-BB与碱性成纤维细胞生长因子联合应用促进血管生成协同作用、维持血管稳定性并改善后肢缺血
Nat Med. 2003 May;9(5):604-13. doi: 10.1038/nm848. Epub 2003 Mar 31.
4
Monotherapy versus combination therapy of angiogenic and arteriogenic factors for the treatment of ischemic disorders.血管生成和动脉形成因子的单药治疗与联合治疗治疗缺血性疾病。
Curr Mol Med. 2009 Nov;9(8):967-72. doi: 10.2174/156652409789712747.
5
Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model.成纤维细胞生长因子-2 和血小板衍生生长因子-BB 对兔后肢缺血模型血管生成和肌肉再生的协同作用。
Microvasc Res. 2010 Jul;80(1):10-7. doi: 10.1016/j.mvr.2009.12.002. Epub 2010 Jan 4.
6
Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction.心肌梗死后藻酸水凝胶序贯释放血管内皮生长因子A165(VEGF-A165)和血小板衍生生长因子BB(PDGF-BB)的血管生成作用
Cardiovasc Res. 2007 Jul 1;75(1):178-85. doi: 10.1016/j.cardiores.2007.03.028. Epub 2007 Apr 6.
7
Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia.在心包内递送成纤维细胞生长因子-2可在慢性心肌缺血猪模型中诱导新生血管形成。
J Pharmacol Exp Ther. 2000 Feb;292(2):795-802.
8
Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression.通过内皮细胞特异性血小板衍生生长因子表达实现血管壁成熟和延长血管生成效应
Pathobiology. 2006;73(3):149-58. doi: 10.1159/000095561.
9
Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure.经心肌内持续递送新型生长因子组合的动脉生成治疗可预防慢性心力衰竭。
Circulation. 2011 Aug 30;124(9):1059-69. doi: 10.1161/CIRCULATIONAHA.110.010264. Epub 2011 Aug 8.
10
Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia.
Ann Thorac Surg. 2000 Dec;70(6):2113-8. doi: 10.1016/s0003-4975(00)02018-x.

引用本文的文献

1
Reinforcing Stromal Cell Spheroid Through Red-Light Preconditioning for Advanced Vascularization.通过红光预处理增强基质细胞球体以促进高级血管生成。
Adv Sci (Weinh). 2025 Aug;12(29):e2500788. doi: 10.1002/advs.202500788. Epub 2025 Apr 25.
2
Targeting angiogenesis in oncology, ophthalmology and beyond.针对肿瘤学、眼科及其他领域的血管生成。
Nat Rev Drug Discov. 2023 Jun;22(6):476-495. doi: 10.1038/s41573-023-00671-z. Epub 2023 Apr 11.
3
Development of L-Lysine-Loaded PLGA Microparticles as a Controlled Release System for Angiogenesis Enhancement.负载L-赖氨酸的聚乳酸-羟基乙酸共聚物微粒作为促进血管生成的控释系统的研发
Pharmaceutics. 2023 Feb 1;15(2):479. doi: 10.3390/pharmaceutics15020479.
4
Inhibition of adenosine kinase attenuates myocardial ischaemia/reperfusion injury.腺苷激酶抑制减轻心肌缺血/再灌注损伤。
J Cell Mol Med. 2021 Mar;25(6):2931-2943. doi: 10.1111/jcmm.16328. Epub 2021 Feb 1.
5
Therapeutic vascular growth in the heart.心脏的治疗性血管生成
Vasc Biol. 2019 Mar 28;1(1):H9-H15. doi: 10.1530/VB-19-0006. eCollection 2019.
6
Cardiovascular disease models: A game changing paradigm in drug discovery and screening.心血管疾病模型:药物发现和筛选的变革性范式。
Biomaterials. 2019 Apr;198:3-26. doi: 10.1016/j.biomaterials.2018.09.036. Epub 2018 Oct 1.
7
Enhanced Neurogenesis and Collaterogenesis by Sodium Danshensu Treatment After Focal Cerebral Ischemia in Mice.丹参素钠治疗小鼠局灶性脑缺血后增强神经发生和侧支生成。
Cell Transplant. 2018 Apr;27(4):622-636. doi: 10.1177/0963689718771889.
8
Therapeutic strategies for cell-based neovascularization in critical limb ischemia.严重肢体缺血中基于细胞的新生血管形成的治疗策略。
J Transl Med. 2017 Feb 24;15(1):49. doi: 10.1186/s12967-017-1153-4.
9
Influence of Androgen Receptor in Vascular Cells on Reperfusion following Hindlimb Ischaemia.血管细胞中的雄激素受体对后肢缺血后再灌注的影响。
PLoS One. 2016 May 9;11(5):e0154987. doi: 10.1371/journal.pone.0154987. eCollection 2016.
10
Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules.对巨噬细胞招募分子局部递送的反应中血管生成的改善
PLoS One. 2015 Jul 1;10(7):e0131643. doi: 10.1371/journal.pone.0131643. eCollection 2015.

本文引用的文献

1
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.舒尼替尼与干扰素α治疗转移性肾细胞癌的对比研究
N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044.
2
Discovery and development of anticancer aptamers.抗癌适体的发现与开发。
Mol Cancer Ther. 2006 Dec;5(12):2957-62. doi: 10.1158/1535-7163.MCT-06-0172.
3
Ranibizumab: treatment in patients with neovascular age-related macular degeneration.雷珠单抗:用于治疗新生血管性年龄相关性黄斑变性患者。
Expert Opin Biol Ther. 2006 Nov;6(11):1237-45. doi: 10.1517/14712598.6.11.1237.
4
Signaling and functions of angiopoietin-1 in vascular protection.血管生成素-1在血管保护中的信号传导与功能
Circ Res. 2006 Apr 28;98(8):1014-23. doi: 10.1161/01.RES.0000218275.54089.12.
5
Role of angiogenesis in cardiovascular disease: a critical appraisal.血管生成在心血管疾病中的作用:批判性评估。
Circulation. 2005 Sep 20;112(12):1813-24. doi: 10.1161/CIRCULATIONAHA.105.535294.
6
Endothelial/pericyte interactions.内皮细胞/周细胞相互作用。
Circ Res. 2005 Sep 16;97(6):512-23. doi: 10.1161/01.RES.0000182903.16652.d7.
7
NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study.慢性心肌缺血患者经心内注射编码血管内皮生长因子A-165的质粒治疗后,采用NOGA指导分析局部心肌灌注异常:EUROINJECT-ONE多中心双盲随机研究的亚分析
Circulation. 2005 Aug 30;112(9 Suppl):I157-65. doi: 10.1161/01.CIRCULATIONAHA.105.525782.
8
Cancer. Encouraging results for second-generation antiangiogenesis drugs.癌症。第二代抗血管生成药物取得了鼓舞人心的成果。
Science. 2005 May 27;308(5726):1248-9. doi: 10.1126/science.308.5726.1248.
9
Angiogenesis: where do we stand now?血管生成:我们目前的进展如何?
Circulation. 2005 Mar 29;111(12):1556-66. doi: 10.1161/01.CIR.0000159345.00591.8F.
10
Growth factor-induced therapeutic angiogenesis in the heart: protein therapy.生长因子诱导的心脏治疗性血管生成:蛋白质疗法
Cardiovasc Res. 2005 Feb 15;65(3):649-55. doi: 10.1016/j.cardiores.2004.09.004.